Exploring the Impact of de Novo Everolimus on Key Determinants of Long Term Outcome After Kidney Transplantation: NODAT, Viral Infection, DSA, Proteinuria and Graft Histology
Phase of Trial: Phase IV
Latest Information Update: 29 Jan 2016
At a glance
- Drugs Everolimus (Primary) ; Ciclosporin; Mycophenolic acid; Tacrolimus
- Indications Renal transplant rejection
- Focus Therapeutic Use
- Acronyms ADVISE
- Sponsors Novartis
- 06 Jan 2016 According to ClinicalTrials.gov record, status changed from not yet recruiting to recruiting.
- 04 Mar 2015 Planned initiation date changed from 1 Dec 2014 to 1 Feb 2015 as reported by ClinicalTrials.gov.
- 17 Dec 2014 New trial record